Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

First launch for Bone Care's novel vitamin D prohormone

Oct. 6, 1999

Flamel Technologies to initiate phase I study of Basulin

Oct. 6, 1999

New study indicates another potential indication for pentoxifylline

Oct. 6, 1999

Novartis pursues development of Src kinase inhibitors for osteoporosis

Oct. 6, 1999

Novo Nordisk investigates new strategy for diabetes and its complications: normoglycemic agents

Oct. 5, 1999

SmithKline Beecham reports advances in vitronectin receptor antagonist research

Oct. 5, 1999

Integrin antagonist S-787 prevents ovariectomy-induced bone loss in rats

Oct. 5, 1999

ASBMR participants learn of efficacy, safety of risedronate in several large studies

Oct. 5, 1999

Compound from Streptomyces inhibits bone resorption, induces apoptosis in osteoclasts in vitro

Oct. 4, 1999

Geranylgeranyltransferase inhibition as a mechanism for specifically inhibiting bone resorption

Oct. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...